Citadel Advisors’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Citadel Advisors’s Portfolio NMRD Stock Details NMRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-41,693	Closed	-$9.38K	–	15861
2023 Q4	$9.38K	Buy	+41,693	New	+$9.98K	﹤0.01%	13155
2021 Q1	–	Sell	-14,721	Closed	-$97.4K	–	13870
2020 Q4	$56K	Sell	14,721 -9,342	-39%	-$36K	﹤0.01%	10533
2020 Q3	$85K	Buy	+24,063	New	+$141K	﹤0.01%	9362
2019 Q4	–	Sell	-4,995	Closed	-$36K	–	9937
2019 Q3	$36K	Buy	+4,995	New	+$42.4K	﹤0.01%	8796
2018 Q4	–	Sell	-1,139	Closed	-$27K	–	9921
2018 Q3	$27K	Sell	1,139 -279	-20%	-$6.93K	﹤0.01%	8954
2018 Q2	$40K	Buy	+1,418	New	+$45.9K	﹤0.01%	8487

Other funds holding NMRD

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Citadel Advisors's NMRD Position: Q1 2024 in Review

Citadel Advisors sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2024, closing a stake of 41,693 shares — an estimated $9.38K sold.

Citadel Advisors first reported a position in NMRD in Q2 2018 and held it in 6 quarters. The position peaked at $85K in Q3 2020. 2 funds tracked by Wall St. Rank hold NMRD as of Q1 2024.

Citadel Advisors reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Citadel Advisors sold 41,693 Nemaura Medical, Inc. Common Stock shares in Q1 2024, an estimated $9.38K.
Citadel Advisors first reported a position in Nemaura Medical, Inc. Common Stock in Q2 2018 and held it in 6 quarters.
Citadel Advisors's Nemaura Medical, Inc. Common Stock position peaked at $85K in Q3 2020.
2 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.